LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3257 | 3769 | 0.8641 | 0.8083 |
BT-20 | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3676 | 3769 | 0.9753 | 0.9651 |
BT-20 | PI103 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3215 | 3769 | 0.8531 | 0.7927 |
BT-20 | QL-XII-47 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1829 | 3769 | 0.4853 | 0.2740 |
BT-20 | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3493 | 3769 | 0.9268 | 0.8968 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3972 | 3769 | 1.0539 | 1.0760 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1423 | 3769 | 0.3775 | 0.1219 |
BT-20 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 724 | 3769 | 0.1921 | -0.1397 |
BT-20 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3192 | 3769 | 0.8469 | 0.7840 |
BT-20 | KIN001-043 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3507 | 3769 | 0.9304 | 0.9019 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 778 | 3769 | 0.2064 | -0.1195 |
BT-20 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3026 | 3769 | 0.8028 | 0.7218 |
BT-20 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2905 | 3769 | 0.7707 | 0.6765 |
BT-20 | AZD 5438 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3015 | 3769 | 0.7998 | 0.7176 |
BT-20 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1604 | 3769 | 0.4256 | 0.1898 |
BT-20 | A443654 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2449 | 3769 | 0.6497 | 0.5058 |
BT-20 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3950 | 3769 | 1.0481 | 1.0678 |
BT-20 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3523 | 3769 | 0.9346 | 0.9077 |
BT-20 | BI-2536 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 876 | 3769 | 0.2324 | -0.0828 |
BT-20 | R406 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3449 | 3769 | 0.9151 | 0.8802 |
BT-20 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2743 | 3769 | 0.7278 | 0.6160 |
BT-20 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3523 | 3769 | 0.9346 | 0.9077 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3336 | 3769 | 0.8850 | 0.8378 |
BT-20 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1280 | 3769 | 0.3396 | 0.0684 |
BT-20 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2367 | 3769 | 0.6280 | 0.4753 |